SRPT vs TMP
Sarepta Therapeutics Inc (SRPT) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
SRPT currently screens at market cap $2.34B. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the SRPT and TMP stock pages for the full models.
Not investment advice.